HUTCHMED (China) HMDCF
NASDAQ HMDCF
$2.16 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

HUTCHMED (China) (HMDCF) Goodwill & Intangibles (2014 - 2025)

HUTCHMED (China)'s (HMDCF) quarterly Goodwill & Intangibles came in at $12.1 million in Q4 2025, up 303.11% year-over-year from $3.0 million in Q4 2024, and up 24.94% quarter-over-quarter from $9.6 million in Q2 2025.

Analysis

HUTCHMED (China) (HMDCF) Goodwill & Intangibles (2014 - 2025) Analysis & Trends

HUTCHMED (China) (HMDCF) has reported Goodwill & Intangibles for 12 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.

  • On a quarterly basis, Goodwill & Intangibles rose 303.11% year-over-year to $12.1 million in Q4 2025; TTM through Dec 2025 was $12.1 million, a 303.11% increase from a year earlier, with the FY2025 full-year figure at $12.1 million, up 303.11% from the prior year.
  • Goodwill & Intangibles was $12.1 million for Q4 2025 at HUTCHMED (China), up from $9.6 million in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $12.1 million in Q4 2025 and troughed at $21000.0 in Q4 2023.
  • A 5-year average of $3.2 million and a median of $194000.0 in 2021 frame the typical range for Goodwill & Intangibles.
  • Across the five-year window, Goodwill & Intangibles tumbled 97.6% in 2022 and surged 14138.1% in 2024, its largest moves.
  • Over 5 years, Goodwill & Intangibles stood at $3.5 million in 2021, then plunged by 97.6% to $85000.0 in 2022, then sank by 75.29% to $21000.0 in 2023, then surged by 14138.1% to $3.0 million in 2024, then surged by 303.11% to $12.1 million in 2025.
  • The last three Goodwill & Intangibles figures came in at $12.1 million (Q4 2025), $9.6 million (Q2 2025), and $3.0 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.50 Bn 197.51 Bn 7.24 Bn
2 Gilead Sciences 181.29 Bn 178.11 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.55 Bn 74.56 Bn 3.93 Bn
5 Argenx Se 61.65 Bn 56.47 Bn 1.37 Bn
6 Moderna 54.65 Bn 49.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.18 Bn 30.87 Bn 992.69 Mn
8 Biogen 31.36 Bn 30.07 Bn 1.96 Bn
9 Roivant Sciences 30.01 Bn 30.01 Bn 1.16 Mn
10 HUTCHMED (China) 376.85 Mn 391.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 12.05 Mn
Jun 30, 2025 9.65 Mn
Dec 31, 2024 2.99 Mn
Dec 31, 2023 21,000.00
Jun 30, 2023 52,000.00
Dec 31, 2022 85,000.00
Jun 30, 2022 122,000.00
Dec 31, 2021 3.54 Mn
Jun 30, 2021 194,000.00
Dec 31, 2020 3.53 Mn
Jun 30, 2020 241,000.00
Dec 31, 2019 3.39 Mn
Sep 30, 2019 288,000.00
Jun 30, 2019 315,000.00
Mar 31, 2019 340,000.00
Dec 31, 2018 3.53 Mn
Jun 30, 2018 403,000.00
Dec 31, 2017 3.74 Mn
Jun 30, 2017 445,000.00
Dec 31, 2016 3.61 Mn